Literature DB >> 11034240

Survival after resection of multiple hepatic colorectal metastases.

S M Weber1, W R Jarnagin, R P DeMatteo, L H Blumgart, Y Fong.   

Abstract

BACKGROUND: Hepatic resection is potentially curative in selected patients with colorectal metastases. It is a widely held practice that multiple colorectal hepatic metastases are not resected, although outcome after removal of four or more metastases is not well defined.
METHODS: Patients with four or more colorectal hepatic metastases who submitted to resection were identified from a prospective database. Number of metastases was determined by serial sectioning of the gross specimen at the time of resection. Demographic data, tumor characteristics, complications, and survival were analyzed.
RESULTS: From August 1985 to September 1998, 155 patients with four or more metastatic tumors (range 4-20) underwent potentially curative resection by extended hepatectomy (39%), lobectomy (42%), or multiple segmental resections (19%). Operative morbidity and mortality were 26% and 1%, respectively. Actuarial 5-year survival was 23% for the entire group (median = 32 months) and there were 12 actual 5-year survivors. On multivariate analysis, only number of hepatic tumors (P = .005) and the presence of a positive margin (P = .003) were independent predictors of poor survival.
CONCLUSIONS: Hepatic resection in patients with four or more colorectal metastases can achieve long-term survival although the results are less favorable as the number of tumors increases. Number of hepatic metastases alone should not be used as a sole contraindication to resection, but it is clear that the majority of patients will not be cured after resection of multiple lesions.

Entities:  

Mesh:

Year:  2000        PMID: 11034240     DOI: 10.1007/s10434-000-0643-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  37 in total

1.  Value of visual inspection, bimanual palpation, and intraoperative ultrasonography during hepatic resection for liver metastases of colorectal carcinoma.

Authors:  Shojiro Hata; Hiroshi Imamura; Taku Aoki; Takuya Hashimoto; Masaaki Akahane; Kiyoshi Hasegawa; Yoshifumi Bekku; Yasuhiko Sugawara; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

2.  Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate.

Authors:  Elie Oussoultzoglou; Philippe Bachellier; Edoardo Rosso; Radu Scurtu; Ioan Lucescu; Michel Greget; Daniel Jaeck
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

3.  Surgical therapy for testicular cancer metastatic to the liver.

Authors:  Mary Maluccio; Lawrence H Einhorn; Robert J Goulet
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 4.  Parenchymal-sparing liver surgery in patients with colorectal carcinoma liver metastases.

Authors:  Fernando A Alvarez; Rodrigo Sanchez Claria; Sebastian Oggero; Eduardo de Santibañes
Journal:  World J Gastrointest Surg       Date:  2016-06-27

5.  SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases.

Authors:  M López-Gómez; J Moreno-Rubio; I Suárez-García; P Cejas; R Madero; E Casado; A Jiménez; M Sereno; C Gómez-Raposo; F Zambrana; M Merino; D Fernández-Luengas; J Feliu
Journal:  Clin Transl Oncol       Date:  2014-07-25       Impact factor: 3.405

6.  Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Authors:  René Adam; Gerard Pascal; Denis Castaing; Daniel Azoulay; Valerie Delvart; Bernard Paule; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

7.  Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy.

Authors:  Ilia Gur; Brian S Diggs; Jesse A Wagner; Gina M Vaccaro; Charles D Lopez; Brett C Sheppard; Susan L Orloff; Kevin G Billingsley
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

8.  Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Chizuru Matsumoto; Kenichi Matsuo; Kazuhisa Takeda; Yasuhiko Nagano; Shinji Togo
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

9.  Incidence and treatment of local site recurrences following RFA of colorectal liver metastases.

Authors:  Karin Nielsen; Aukje A J M van Tilborg; Martijn R Meijerink; Matessa O Macintosh; Babs M Zonderhuis; Elly S M de Lange; Emile F I Comans; Sybren Meijer; M Petrousjka van den Tol
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

10.  Surgical treatment of liver metastases from colorectal cancer in elderly patients.

Authors:  Gianluca Mazzoni; Adriano Tocchi; Michelangelo Miccini; Elia Bettelli; Diletta Cassini; Monica De Santis; Lidia Colace; Stefania Brozzetti
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.